Clarus Therapeutics Holdings, Inc. - ROE

The ROE as of June 2026 (TTM) for Clarus Therapeutics Holdings, Inc. (CRXTQ) is -462.78%

According to Clarus Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -462.78%. This represents a change of -662.88% compared to the average of 82.22% of the last 4 quarters.

Clarus Therapeutics Holdings, Inc. (CRXTQ) Historical ROE (quarterly & annually)

How has CRXTQ ROE performed in the past?

The mean historical ROE of Clarus Therapeutics Holdings, Inc. over the last ten years is 177.50%. The current -462.78% ROE has changed -360.73% with respect to the historical average. Over the past ten years (40 quarters), CRXTQ's ROE was at its highest in in the March 2021 quarter at 212.93%. The ROE was at its lowest in in the June 2020 quarter at 0%.

Clarus Therapeutics Holdings, Inc. (CRXTQ) ROE by Quarter and Year

Discovering the peaks and valleys of Clarus Therapeutics Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clarus Therapeutics Holdings, Inc. (CRXTQ) Average ROE

How has CRXTQ ROE performed in the past?

The current ROE of Clarus Therapeutics Holdings, Inc. (CRXTQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Clarus Therapeutics Holdings, Inc. (CRXTQ) ROE vs. Peers

How is CRXTQ’s ROE compared to its peers?

Clarus Therapeutics Holdings, Inc.’s ROE is less than Endo International plc (60.16%), greater than Nexeon MedSystems Inc. (-18.78%), less than Health-Chem Corporation (10.51%), greater than Invitae Corporation (-201.69%), less than PotNetwork Holdings, Inc. (258.08%), greater than Predictive Technology Group, Inc. (-155.36%), greater than Ontrak, Inc. (-166.05%), greater than Aleafia Health Inc. (-58.25%), greater than Unrivaled Brands, Inc. (-363.56%), greater than Skylight Health Group Inc. (-47.81%),

Build a custom stock screener for Clarus Therapeutics Holdings, Inc. (CRXTQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clarus Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clarus Therapeutics Holdings, Inc. (CRXTQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clarus Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.